Regulation of 26S proteasome activity in pulmonary fibrosis

American Journal of Respiratory and Critical Care Medicine

Volumn 192, Issue 9, 2015, Pages 1089-1101

  Semren, Nora ^a   Welk, Vanessa ^a   Korfei, Martina ^b   Keller, Ilona E ^a   Fernandez, Isis E ^a   Adler, Heiko ^c   Günther, Andreas ^b,d,e   Eickelberg, Oliver ^a   Meiners, Silke ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b JUSTUS LIEBIG UNIVERSITY GIESSEN   (Germany)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

^d Agaplesion Lung Clinic Waldhof Elgershausen   (Germany)

^e European IPF Network and European IPF Registry   (Germany)

Author keywords

Idiopathic pulmonary fibrosis; Myofibroblast differentiation; Proteasome

Indexed keywords

26S PROTEASOME; BORTEZOMIB; CYCLIN D1; GAMMA INTERFERON RECEPTOR; PROTEASOME; PROTEIN; RPN6 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; ATP DEPENDENT 26S PROTEASE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BASAL CELL; BLEOMYCIN-INDUCED PULMONARY FIBROSIS; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED STUDY; EMBRYONIC STEM CELL; FEMALE; G1 PHASE CELL CYCLE CHECKPOINT; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LUNG FIBROBLAST; LUNG FUNCTION; MALE; MIDDLE AGED; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UBIQUITINATION; UPREGULATION; ANIMAL; CELL CULTURE TECHNIQUE; DISEASE MODEL; FIBROSING ALVEOLITIS; LUNG; METABOLISM; MYOFIBROBLAST; PATHOPHYSIOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; LUNG; MALE; MICE; MIDDLE AGED; MYOFIBROBLASTS; PROTEASOME ENDOPEPTIDASE COMPLEX; SIGNAL TRANSDUCTION;

EID: 84946549253     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201412-2270OC     Document Type: Article

References (60)

1. Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, Colby TV, Cordier JF, Flaherty KR, Lasky JA, et al.; ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit CareMed 2011;183:788-824.
2. Fernandez IE, Eickelberg O. New cellular and molecular mechanisms of lung injury and fibrosis in idiopathic pulmonary fibrosis. Lancet 2012;380:680-688.
3. Wynn TA. Integrating mechanisms of pulmonary fibrosis. J Exp Med 2011;208:1339-1350.
4. Wynn TA, Ramalingam TR. Mechanisms of fibrosis: therapeutic translation for fibrotic disease. Nat Med 2012;18:1028-1040.
5. Duffield JS, Lupher M, Thannickal VJ, Wynn TA. Host responses in tissue repair and fibrosis. Annu Rev Pathol 2013;8:241-276.
6. Powers ET, Balch WE. Diversity in the origins of proteostasis networks- a driver for protein function in evolution. Nat Rev Mol Cell Biol 2013;14:237-248.
7. Balch WE, Morimoto RI, Dillin A, Kelly JW. Adapting proteostasis for disease intervention. Science 2008;319:916-919.
8. Vilchez D, Simic MS, Dillin A. Proteostasis and aging of stem cells. Trends Cell Biol 2014;24:161-170.
9. Zhang Y, Nicholatos J, Dreier JR, Ricoult SJH, Widenmaier SB, Hotamisligil GS, Kwiatkowski DJ, Manning BD. Coordinated regulation of protein synthesis and degradation by mTORC1. Nature 2014;513:440-443.
10. Buszczak M, Signer RAJ, Morrison SJ. Cellular differences in protein synthesis regulate tissue homeostasis. Cell 2014;159:242-251.
11. Finley D. Recognition and processing of ubiquitin-protein conjugates by the proteasome. Annu Rev Biochem 2009;78:477-513.
12. Ciechanover A. Intracellular protein degradation: from a vague idea thru the lysosome and the ubiquitin-proteasome system and onto human diseases and drug targeting. Cell Death Differ 2005;12:1178-1190.
13. Teixeira LK, Reed SI. Ubiquitin ligases and cell cycle control. Annu Rev Biochem 2013;82:387-414.
14. Bhattacharyya S, Yu H, Mim C, Matouschek A. Regulated protein turnover: snapshots of the proteasome in action. Nat Rev Mol Cell Biol 2014;15:122-133.
15. Groll M, Bajorek M, Köhler A, Moroder L, Rubin DM, Huber R, Glickman MH, Finley D. A gated channel into the proteasome core particle. Nat Struct Biol 2000;7:1062-1067.
16. Tomko RJ Jr, Hochstrasser M. Molecular architecture and assembly of the eukaryotic proteasome. Annu Rev Biochem 2013;82:415-445.
17. Lander GC, Estrin E, Matyskiela ME, Bashore C, Nogales E, Martin A. Complete subunit architecture of the proteasome regulatory particle. Nature 2012;482:186-191.
18. Liu CW, Jacobson AD. Functions of the 19S complex in proteasomal degradation. Trends Biochem Sci 2013;38:103-110.
19. Meiners S, Keller IE, Semren N, Caniard A. Regulation of the proteasome: evaluating the lung proteasome as a new therapeutic target. Antioxid Redox Signal 2014;21:2364-2382.
20. Balch WE, Sznajder JI, Budinger S, Finley D, Laposky AD, Cuervo AM, Benjamin IJ, Barreiro E, Morimoto RI, Postow L, et al. Malfolded protein structure and proteostasis in lung diseases. Am J Respir Crit Care Med 2014;189:96-103.
21. Mutlu GM, Budinger GRS, Wu M, Lam AP, Zirk A, Rivera S, Urich D, Chiarella SE, Go LHT, Ghosh AK, et al. Proteasomal inhibition after injury prevents fibrosis by modulating TGF-b1 signalling. Thorax 2012;67:139-146.
22. Semren N, Fernandez IE, Günther A, Eickelberg O. Proteasome function in lung fibrosis. Presented at the Munich Lung Conference 2013. September 4-5, 2013, Munich, Germany.
23. Semren N, Fernandez IE, Günther A, Eickelberg O, Meiners S. Regulation of the proteasome in lung fibrosis. Presented at the ERS Annual Congress 2013. September 7-11, 2013, Barcelona, Spain.
24. Semren N, Welk V, Korfei M, Fernandez IE, Günther A, Eickelberg O, Meiners S. Proteasome function in lung fibrosis. Presented at the ERS International Congress 2014. September 6-10, 2014, Munich, Germany.
25. Semren N, Welk V, Korfei M, Fernandez IE, Günther A, Eickelberg O, Meiners S. Altered proteasome function in lung fibrosis. Presented at the American Thoracic Society 2014 International Conference. May 16-21, 2014, San Diego, CA.
26. Semren N, Welk V, Korfei M, Fernandez IE, Günther A, Eickelberg O, Meiners S. Altered proteasome function in lung fibrosis. Presented at the Third International DZL Symposium. May 8-10, 2014, Hannover, Germany.
27. Korfei M, Schmitt S, Ruppert C, Henneke I, Markart P, Loeh B, Mahavadi P, Wygrecka M, Klepetko W, Fink L, et al. Comparative proteomic analysis of lung tissue from patients with idiopathic pulmonary fibrosis (IPF) and lung transplant donor lungs. J Proteome Res 2011;10:2185-2205.
28. Jordana M, Newhouse MT, Gauldie J. Alveolar macrophage/peripheral blood monocyte-derived factors modulate proliferation of primary lines of human lung fibroblasts. J Leukoc Biol 1987;42:51-60.
29. Jordana M, Befus AD, Newhouse MT, Bienenstock J, Gauldie J. Effect of histamine on proliferation of normal human adult lung fibroblasts. Thorax 1988;43:552-558.
30. van Rijt SH, Keller IE, John G, Kohse K, Yildirim AÖ, Eickelberg O, Meiners S. Acute cigarette smoke exposure impairs proteasome function in the lung. Am J Physiol Lung Cell Mol Physiol 2012;303:L814-L823.
31. John G, Kohse K, Orasche J, Reda A, Schnelle-Kreis J, Zimmermann R, Schmid O, Eickelberg O, Yildirim AÖ. The composition of cigarette smoke determines inflammatory cell recruitment to the lung in COPD mouse models. Clin Sci (Lond) 2014;126:207-221.
32. Aumiller V, Balsara N, Wilhelm J, Günther A, Königshoff M. WNT/b-catenin signaling induces IL-1b expression by alveolar epithelial cells in pulmonary fibrosis. Am J Respir Cell Mol Biol 2013;49:96-104.
33. Marques AJ, Palanimurugan R, Matias AC, Ramos PC, Dohmen RJ. Catalytic mechanism and assembly of the proteasome. Chem Rev 2009;109:1509-1536.
34. Vilchez D, Boyer L, Morantte I, Lutz M, Merkwirth C, Joyce D, Spencer B, Page L, Masliah E, Berggren WT, et al. Increased proteasome activity in human embryonic stem cells is regulated by PSMD11. Nature 2012;489:304-308.
35. Mora AL, Woods CR, Garcia A, Xu J, Rojas M, Speck SH, Roman J, Brigham KL, Stecenko AA. Lung infection with g-herpesvirus induces progressive pulmonary fibrosis in Th2-biased mice. Am J Physiol Lung Cell Mol Physiol 2005;289:L711-L721.
36. Zhang H, Xing L. Ubiquitin E3 ligase itch negatively regulates osteoblast differentiation from mesenchymal progenitor cells. Stem Cells 2013;31:1574-1583.
37. Cravatt BF, Wright AT, Kozarich JW. Activity-based protein profiling: from enzyme chemistry to proteomic chemistry. Annu Rev Biochem 2008;77:383-414.
38. Yang K, Hitomi M, Stacey DW. Variations in cyclin D1 levels through the cell cycle determine the proliferative fate of a cell. Cell Div 2006;1:32.
39. Soond SM, Chantry A. How ubiquitination regulates the TGF-b signalling pathway: new insights and new players: new isoforms of ubiquitin-activating enzymes in the E1-E3 families join the game. Bioessays 2011;33:749-758.
40. Pathare GR, Nagy I, Bohn S, Unverdorben P, Hubert A, Körner R, Nickell S, Lasker K, Sali A, Tamura T, et al. The proteasomal subunit Rpn6 is a molecular clamp holding the core and regulatory subcomplexes together. Proc Natl Acad Sci USA 2012;109:149-154.
41. Vilchez D, Morantte I, Liu Z, Douglas PM, Merkwirth C, Rodrigues APC, Manning G, Dillin A. RPN-6 determines C. elegans longevity under proteotoxic stress conditions. Nature 2012;489:263-268.
42. Baker TA, Bach HH IV, Gamelli RL, Love RB, Majetschak M. Proteasomes in lungs from organ donors and patients with end-stage pulmonary diseases. Physiol Res 2014;63:311-319.
43. Liu G, Rogers J, Murphy CT, Rongo C. EGF signalling activates the ubiquitin proteasome system to modulate C. elegans lifespan. EMBO J 2011;30:2990-3003.
44. Mearini G, Schlossarek S, Willis MS, Carrier L. The ubiquitinproteasome system in cardiac dysfunction. Biochim Biophys Acta 2008;1782:749-763.
45. Schmidt M, Finley D. Regulation of proteasome activity in health and disease. Biochim Biophys Acta 2014;1843:13-25.
46. Meiners S, Hocher B, Weller A, Laule M, Stangl V, Guenther C, Godes M, Mrozikiewicz A, Baumann G, Stangl K. Downregulation of matrix metalloproteinases and collagens and suppression of cardiac fibrosis by inhibition of the proteasome. Hypertension 2004;44:471-477.
47. Koca SS, Ozgen M, Dagli F, Tuzcu M, Ozercan IH, Sahin K, Isik A. Proteasome inhibition prevents development of experimental dermal fibrosis. Inflammation 2012;35:810-817.
48. Fineschi S, Bongiovanni M, Donati Y, Djaafar S, Naso F, Goffin L, Argiroffo CB, Pache JC, Dayer JM, Ferrari-Lacraz S, et al. In vivo investigations on anti-fibrotic potential of proteasome inhibition in lung and skin fibrosis. Am J Respir Cell Mol Biol 2008;39:458-465.
49. Fineschi S, Reith W, Guerne PA, Dayer JM, Chizzolini C. Proteasome blockade exerts an antifibrotic activity by coordinately downregulating type I collagen and tissue inhibitor of metalloproteinase-1 and up-regulating metalloproteinase-1 production in human dermal fibroblasts. FASEB J 2006;20:562-564.
50. Meiners S, Ludwig A, Stangl V, Stangl K. Proteasome inhibitors: poisons and remedies. Med Res Rev 2008;28:309-327.
51. Di Napoli M, McLaughlin B. The ubiquitin-proteasome system as a drug target in cerebrovascular disease: therapeutic potential of proteasome inhibitors. Curr Opin Investig Drugs 2005;6:686-699.
52. Moore BB, Lawson WE, Oury TD, Sisson TH, Raghavendran K, Hogaboam CM. Animal models of fibrotic lung disease. Am J Respir Cell Mol Biol 2013;49:167-179.
53. Moeller A, Ask K, Warburton D, Gauldie J, Kolb M. The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis? Int J Biochem Cell Biol 2008;40:362-382.
54. Moore BB, Hogaboam CM. Murine models of pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 2008;294:L152-L160.
55. Weiss CH, Budinger GRS, Mutlu GM, Jain M. Proteasomal regulation of pulmonary fibrosis. Proc Am Thorac Soc 2010;7:77-83.
56. Eldridge AG, O'Brien T. Therapeutic strategies within the ubiquitin proteasome system. Cell Death Differ 2010;17:4-13.
57. D'Arcy P, Brnjic S, Olofsson MH, Fryknäs M, Lindsten K, De Cesare M, Perego P, Sadeghi B, Hassan M, Larsson R, et al. Inhibition of proteasome deubiquitinating activity as a new cancer therapy. Nat Med 2011;17:1636-1640.
58. Lander GC, Martin A, Nogales E. The proteasome under the microscope: the regulatory particle in focus. Curr Opin Struct Biol 2013;23:243-251.
59. Tanaka K, Mizushima T, Saeki Y. The proteasome: molecular machinery and pathophysiological roles. Biol Chem 2012;393:217-234.
60. Gaczynska M, Osmulski PA. Targeting protein-protein interactions in the proteasome super-assemblies. Curr Top Med Chem 2015;15:2056-2067.